Email address
[email protected]Contact number
+1 212 558 4000Share profile
Band 5
Provided by Keith Pagnani
General Practice; Artificial Intelligence; Corporate Governance; Healthcare & Life Sciences; Financial Services; Intellectual Property & Technology Transactions; Latin America M&A and Joint Ventures; M&A Financial Advisory and Valuation; Mergers & Acquisitions; Private Equity; Technology
Keith Pagnani is a partner in S&C’s Mergers & Acquisitions Group, Co-Head of Mergers & Acquisitions, North America, and Co-Head of the Firm’s Healthcare and Life Sciences Group. Keith is actively involved in S&C’s corporate practice and has broad experience in domestic and cross-border M&A transactions. He is a recognized leader in the healthcare and pharmaceuticals industry, and has been recognized as The American Lawyer’s “Dealmaker of the Week” for advising UnitedHealth in OptumRx’s combination with Catamaran and “Dealmaker of the Year” for advising Alcon’s independent directors committee in Alcon’s acquisition by Novartis. Keith has also been recognized as “Global M&A Lawyer of the Year” at The M&A Atlas Awards, a “Healthcare Trailblazer” by The National Law Journal and one of Lawdragon’s 2025 “500 Leading Dealmakers in America.”
Recent representations include: Booking Holdings in its $1.2 billion acquisition of Getaroom; Harris’s $35 billion merger of equals with L3 Technologies to form L3Harris Technologies and L3Harris’ approximately $1.96 billion acquisition of Viasat’s Tactical Data Links product line and $1.05 billion sale of its Military Training business to CAE; Kidde-Fenwal in the pending sale of assets of Carrier Group to an affiliate of Pacific Avenue Capital Partners; Lazard in its conversion from a publicly traded partnership to a U.S. C-Corporation under Delaware Law and changing its name from Lazard Ltd to Lazard, Inc.; Linde on its delisting from the Frankfurt Stock Exchange by way of an Irish scheme of arrangement and a subsequent inter-company merger; Praxair’s $80 billion merger of equals with Linde; Special Committee of the Board of Directors of Teck Resources in the dropped spin-off of Elk Valley Resources, and the six-year sunset for the multiple voting rights attached to the Class A common shares of Teck; UnitedHealth in Optum’s $3.7 billion acquisition of Amedisys, $6 billion merger with LHC Group, $13.8 billion acquisition of Change Healthcare and the divestiture of ClaimsXten to an affiliate of investment funds of TPG Capital for $2.2 billion and $4.3 billion acquisition of DaVita Medical; and Delta’s agreement with Air France-KLM to acquire a 10% stake in Air France.
Member, Tulane University Law School’s Corporate Law Institute Planning Committee; Chair of the Board of P.O.T.S. (Part of the Solution).
Catholic University of America Columbus School of Law (JD, 1989); Dickinson College (BA, 1986).
Provided by Chambers
Keith Pagnani offers deep expertise in domestic and cross-border M&A to a stable of clients consisting of corporates and financial advisers. He sits as co-head of the firm's healthcare and life sciences group.